Aesther Healthcare Acquisition Corp.
Definitive Agreement
Follow
Detailed Information
Information on this SPAC.
- IPO Size
- $100M
- Underwriters
- Focus
- Pharmaceuticals
- SEC Filings
- 1869974
SPAC Leadership
Information on the SPAC leadership.
- Chairman, Chief Executive Officer and DirectorSuren Ajjarapu(Chairman & CEO of TRxADE Health)
- Chief Financial Officer and SecretaryHoward A. Doss
- DirectorMichael L. Peterson
- DirectorVenkatesh Srinivasan
- DirectorDonald G. Fell
- DirectorSiva Saravanan
Target Information
Information on the SPAC target for merger.
- Company
- Ocean Biomedical, Inc.